PAO Group, Inc.

Recent News

  • PAOG Highlights ALKM $15 Million Production Facility In Conjunction With CBD Nutraceutical Plan Targeting $5 Billion Market

    Sandusky, Ohio--(Newsfile Corp. - May 27, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today highlighted Alkame Holdings, Inc's (OTC Pink: ALKM) recent news reporting the near completion status of its new production facility:ALKM - Alkame Confirms $15 Million Annual Revenue Bottling Production PotentialPAOG recenlty released a preview of the company's plan to launch a CBD Nutraceuticals line of products. PAOG's CBD Nutraceuticals are expected to generate revenue this year, in 2021, while the company continues with its long-term...

    2021-05-27 2:34 PM EDT
  • PAOG Targets International Segment of $5 Billion CBD Nutraceutical Market

    Sandusky, Ohio--(Newsfile Corp. - May 13, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today revealed it will include foreign sales in the planned Q4 launch of its three CBD Nutraceutical Products.The 2020 CBD Nutraceuticals Market had an estimated value of $5.2 Billion and it is expected to reach $16.4 Billion by 2027.That market value represents global sales. PAOG management is targeting specific international segments to be included in its Q4 sales launch. PAOG management anticipates a...

    2021-05-13 9:22 AM EDT
  • PAOG Confirms CBD Nutraceutical Q4 Revenue Plans

    Sandusky, Ohio--(Newsfile Corp. - May 11, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed plans to introduce three CBD Nutraceutical Products beginning in the fourth quarter of this year, 2021.On Friday, PAOG released a preview of the company's plan to launch a CBD Nutraceuticals line of products. PAOG's CBD Nutraceuticals are expected to generate revenue this year, in 2021, while the company continues with its long-term CBD pharmaceutical developments.PAOG is working on the development of a CBD...

    2021-05-11 2:58 PM EDT
  • PAOG Releases CBD Nutraceutical 2021 Product Launch Preview Highlighting PURA EVERx Partnership, ALKM Co-Packing and USMJ Distribution

    Sandusky, Ohio--(Newsfile Corp. - May 7, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today released a preview of the company's plan to launch a CBD Nutraceuticals line of products. PAOG's CBD Nutraceuticals are expected to generate revenue this year, in 2021, while the company continues with its long-term CBD pharmaceutical developments.PAOG is working on the development of a CBD pharmaceutical product under the name RespRx, for the treatment of Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented...

    2021-05-07 8:42 AM EDT
  • PAOG 2021 CBD Nutraceuticals Rollout Preview This Friday

    Sandusky, Ohio--(Newsfile Corp. - May 5, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed a CBD Nutraceutical Sales Rollout Presentation scheduled this Friday, May 7, 2021.Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT."PAOG is working with Veristat,...

    2021-05-05 12:12 PM EDT
  • PAOG CBD Nutraceuticals to Hit Market This Year

    Sandusky, Ohio--(Newsfile Corp. - May 4, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed plans to present the Company's CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021.Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled, "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT."PAOG...

    2021-05-04 8:59 AM EDT
  • PAOG 2021 CBD Nutraceutical Sales Rollout Plan Presentation Scheduled This Friday

    Sandusky, Ohio--(Newsfile Corp. - May 3, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced plans to present the company's CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021.Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled "METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT."PAOG...

    2021-05-03 3:22 PM EDT
  • PAOG Anticipates Boost to CBD Pharmaceutical Research Initiative from Improving Cannabis Legalization Outlook

    Sandusky, Ohio--(Newsfile Corp. - April 28, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today highlighted recent cannabis legalization progress anticipated to enhance PAOG's ongoing CBD Pharmaceutical Development Program.PAOG has partnered with Puration, Inc. (OTC Pink: PURA) to build a pharmaceutical grade indoor hemp grow facility and CBD extraction facility in conjunction with PURA's Farmersville Hemp Brand project in Texas. PURA Farmersville Hemp Brand project partners also include Alkame Holdings, Inc. (OTC Pink: ALKM) and North American Cannabis Holdings,...

    2021-04-28 12:13 PM EDT